Novotech, a top global clinical trial provider, partners with biotech and pharma to speed siRNA therapeutic development.
New bacterial nanocellulose-covered stents integrate seamlessly with tissues, deliver drugs precisely, and promise safer ...
A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...
Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...
7d
Enhanced Regenerative Potential: Stem cell-derived exosomes accelerate wound healing and tissue regeneration. Market Research Future Market Research Future +1 855-661-4441 email us here Visit us on ...
Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...
The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...
Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for ... creating a new application space for T cell-specific therapies." Business Highlights Applying T ...
Company is applying its T cell-selective lipid nanoparticle ... space for T cell-specific therapies.” Business Highlights Delivering siRNA with a T cell-selective LNP could enable selective modulation ...
In the manuscript entitled 'A comparative analysis of planarian regeneration specificity reveals tissue polarity contributions of the axial cWnt signalling gradient.' Cleland et al. study the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback